How does a pacemaker work and what does it do when the heart beats too fast?
Pacemakers and defibrillators act on the heart's signals according to programmed timing, so unusual ECG patterns often reflect normal device behaviour rather than a fault.
Covers: How implanted pacemakers sense and pace the heart, the difference between pacing for slow rhythms and treatments for fast rhythms (antitachycardia pacing, defibrillation, and pacemaker-mediated tachycardia), and how devices are programmed. It does not cover surgical technique or individual treatment decisions.
Also answers: What does a pacemaker do for a fast heartbeat? · How do pacemakers sense and pace the heart? · Can a pacemaker slow down a fast heart rate? · Pacemaker vs ICD for fast heart rhythms
- One page for this question6 other ways of asking lead here
- 5 independent sourcesEvery claim links to what supports it
- 1 connected page1 changed this week
- Clean discussionScreened before anything appears
The short answer
Interpretation AI-prepared starting mapAn implanted pacemaker watches the heart's own electrical activity and delivers small electrical pulses when the heart beats too slowly or when conduction fails. For fast rhythms the picture splits: pacemakers and defibrillators can deliver antitachycardia pacing (ATP) — rapid bursts of pacing intended to interrupt an arrhythmia — and defibrillators can…123
Read the full explanation and caveatsAt a glance
The picture in numbers
Live · updated just now
63 documents
8,032 patients
130 bpm
The evidence behind it
5 sources- Other studies and data5
When it was published
Newest from 2026
| Source | Kind | Year |
|---|---|---|
| Fundamentals of pacemakers ECG interpretation - part 2. | Other studies and data | 2026 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy | Other studies and data | 2021 |
| Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias | Other studies and data | 2019 |
| ANTITACHYCARDIA PACING: OPTIMAL PROGRAMMING AND PREDICTION OF EFFICACY FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS. STATE OF THE ART AND PERSPECTIVE. | Other studies and data | 2023 |
| When the Pacemaker Goes Rogue: Pacemaker-Induced Tachycardia, Syncope, and Car Crash. | Other studies and data | 2026 |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
Did this answer your question?
Be the first to voteIn brief
A pacemaker senses the heart's own signals and paces when beats are too slow or conduction fails; programmed timing intervals and refractory periods determine exactly when it acts.1
Evidence-backedFor fast ventricular rhythms, ICDs can use antitachycardia pacing to interrupt the arrhythmia and avoid a shock, and good programming can reduce inappropriate or avoidable ATP.2
Evidence-backedReactive atrial-based ATP was associated with fewer longer-lasting atrial tachyarrhythmia/AF events (HR 0.56 for events of 30+ days) in a large matched device-database analysis.4
Evidence-backedA pacemaker can itself cause a fast rhythm (PMT) by tracking retrograde atrial signals; in a reported case this produced 130 bpm tachycardia with severe hypotension and syncope, resolved by switching from DDD to DDIR.3
Evidence-backedMany unusual ECG patterns — pseudo-Wenckebach, apparent AV block, abrupt rate drops — are normal consequences of device algorithms rather than malfunction.1
Evidence-backed
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you see Wenckebach-like behaviour or a 2:1 pattern on a paced ECG
consider that upper rate behaviour of the device can mimic Mobitz type I or second-degree AV block, and check the programmed upper rate and timing intervals before calling it conduction disease.1
Evidence-backedIf an abrupt rate drop appears on a paced ECG
mode switching can cause abrupt rate drops that are misidentified as output failure; review the device's mode-switch settings and event log.1
Evidence-backedIf you notice a conspicuously short, fixed AV interval
this is the expected signature of ventricular safety pacing rather than a fault.1
Evidence-backedIf a patient with a pacemaker has recurrent fast rhythms with hypotension or syncope
PMT should be considered; in the reported case the fix was reprogramming from DDD to DDIR to prevent atrial tracking, and PVARP prolongation was not feasible because of slow ventriculoatrial conduction.3
Evidence-backedIf you are weighing therapies for fast ventricular rhythms in a patient with an ICD
ATP can interrupt ventricular arrhythmias and avoid shocks, and optimal ICD programming can reduce inappropriate or avoidable ATP therapies.2
Evidence-backedIf you are deciding whether to enable reactive atrial-based ATP
the available evidence is an association from a large device database (lower risk of atrial tachyarrhythmia/AF events of 1, 7 and 30+ days), not a randomised trial, so weigh it as supportive rather than definitive.4
InterpretationIf you are making device or programming decisions for an individual patient
treat these as clinical judgements for the care team, made with the patient and subject to current official guidance and device regulations.5
Evidence-backedThe full explanation
Interpretation AI-prepared starting mapAn implanted pacemaker watches the heart's own electrical activity and delivers small electrical pulses when the heart beats too slowly or when conduction fails. For fast rhythms the picture splits: pacemakers and defibrillators can deliver antitachycardia pacing (ATP) — rapid bursts of pacing intended to interrupt an arrhythmia — and defibrillators can also shock; separately, a pacemaker can itself cause a fast rhythm (pacemaker-mediated tachycardia, PMT) when it tracks atrial signals that are conducted back up from the ventricles. How the device behaves in each case depends heavily on programmed timing intervals and refractory periods, which is why device-driven ECG patterns can mimic genuine arrhythmia or malfunction.123
- Evidence 19
- Interpretation 3
The full story · 3 chapters
01
Sensing the heart and pacing when it beats too slowly
AI summary:The device senses intrinsic signals and paces when beats are too slow, and many odd ECG patterns are normal results of its timing algorithms.
Evidence-backed: A pacemaker works by continuously monitoring the heart's intrinsic electrical signals and stepping in with pacing pulses when they are absent or too slow. The device's behaviour is governed by programmed timing intervals and refractory periods — the windows during which the device ignores signals or withholds pacing. Understanding these intervals is what lets a clinician tell programmed behaviour apart from true malfunction or a genuine arrhythmia.1
Evidence-backed: Several routine algorithms change what pacing looks like on an ECG without anything being wrong. Upper rate Wenckebach behaviour mimics Mobitz type I AV block, and a 2:1 upper rate response mimics second-degree AV block. Ventricular pacing minimization algorithms can produce isolated nonconducted P waves and prolonged AV intervals that look like conduction disease. Mode switching causes abrupt rate drops that can be mistaken for output failure, and ventricular safety pacing produces a conspicuously short, fixed AV interval. Rate and AV hysteresis produce pauses and wandering AV intervals that mimic oversensing or Wenckebach periodicity.1
Evidence-backed: Three discrete pacing artifacts can reflect AV-sequential cardiac resynchronization therapy (CRT), ventricular safety pacing in CRT, or His-bundle pacing with backup right-ventricular output. In each case the pattern is a product of the device's design and settings rather than a fault.1
02
What devices do when the heart beats too fast
AI summary:Devices can pace rapidly to interrupt fast rhythms, but a pacemaker can also itself cause a fast rhythm by tracking retrograde atrial signals.
Evidence-backed: For fast ventricular rhythms, antitachycardia pacing (ATP) is one of the therapies an implantable cardioverter defibrillator (ICD) provides. Successful ATP interrupts the arrhythmia and avoids a shock, and shocks are linked to increased mortality and morbidity — so avoiding them matters. A review of 63 documents concluded that ATP is a good tool for interrupting ventricular arrhythmias, and that optimal ICD programming can reduce inappropriate or avoidable ATP therapies. Better knowledge of the factors that predict whether ATP will work could also guide device choice and arrhythmic risk stratification.2
Evidence-backed: Pacemakers can also act on fast atrial rhythms. In a matched analysis from a large device database, 4,016 matched pairs (8,032 patients) were compared, and patients with reactive atrial-based ATP (rATP) enabled had significantly lower risks of atrial tachyarrhythmia/atrial fibrillation events lasting at least 1 day (hazard ratio 0.81), at least 7 days (HR 0.64) and at least 30 days (HR 0.56), all with P < 0.0001. The association held across age, sex, device type, baseline atrial tachyarrhythmia and preventive atrial pacing, and was independent of whether the patient had a pacemaker, defibrillator or resynchronization device.4
Evidence-backed: A pacemaker can also be the cause of a fast rhythm. In pacemaker-mediated tachycardia (PMT), the device tracks atrial signals that are conducted back up from the ventricles and paces the ventricles rapidly in response. In one reported case, atrial threshold testing provoked a PMT at 130 bpm with severe symptomatic hypotension (mean blood pressure below 50 mmHg), reproducible several times; given severe left ventricular systolic dysfunction and no other explanation, the PMT likely triggered syncope preceding a car accident. Management focused on reprogramming: the key change was a mode switch from DDD to DDIR to prevent atrial tracking, which terminated the PMT episodes. Prolonging the postventricular atrial refractory period (PVARP) was not possible because of very slow ventriculoatrial conduction. Follow-up showed no further PMT and no further presyncope or syncope.3
Evidence-backed: Distinguishing a device-driven fast rhythm from a true arrhythmia again comes down to timing intervals and refractory periods. Ventricular tachycardia is identified by a QRS morphology that diverges from the known paced pattern, absent pacing spikes and AV dissociation — features a clinician compares against the device's programmed behaviour.1
03
Why programming decides what the device does
AI summary:Mode, refractory periods and rate limits decide how the device behaves, and each setting leaves a recognisable signature on the ECG.
Interpretation: The same hardware behaves very differently depending on how it is programmed. Mode choice (for example DDD versus DDIR), refractory periods such as PVARP, upper rate limits, safety pacing and pacing-minimization algorithms all shape whether the device paces, tracks, withholds therapy or switches mode — and each leaves a recognisable signature on the ECG. The PMT case shows this directly: changing the mode to prevent atrial tracking stopped the tachycardias, while a PVARP-based fix was ruled out by the patient's slow ventriculoatrial conduction.31
Evidence-backed: Guidelines frame programming and device decisions as clinical judgements for the care team, made with the individual patient (and where appropriate their caregiver) in light of that patient's condition, and subject to updated official recommendations and device regulations. They do not override the treating professional's responsibility for individual decisions.5
Before you go
What to remember
Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.
A pacemaker can itself cause a fast rhythm (PMT) by tracking retrograde atrial signals; in a reported case this produced bpm tachycardia with severe hypotension and syncope, resolved by switching from DDD to DDIR.
A pacemaker senses the heart's own signals and paces when beats are too slow or conduction fails; programmed timing intervals and refractory periods determine exactly when it acts.
For fast ventricular rhythms, ICDs can use antitachycardia pacing to interrupt the arrhythmia and avoid a shock, and good programming can reduce inappropriate or avoidable ATP.
Your reading
0 of 3 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Fundamentals of pacemakers ECG interpretation - part 2.Journal of electrocardiology (de et al.)Published Jul 14, 2026Checked Oct 17, 2026
“Ventricular tachycardia is identified by QRS morphology diverging from the known paced pattern, absent pacing spikes, and AV dissociation. Upper rate Wenckebach behavior mimics Mobitz type I AV block; 2:1 upper rate response mimics second-degree AV block. Ventricular pacing minimization algorithms produce isolated nonconducted P waves and prolonged AV intervals that simulate pathological conduction disease. Mode switching causes abrupt rate drops misidentified as output failure. Ventricular safety pacing generates a conspicuously short, fixed AV interval. Three discrete pacing artifacts reflect AV-sequential cardiac resynchronization therapy (CRT), ventricular safety pacing in CRT, or His-bundle pacing with backup RV output. Rate and AV hysteresis produce pauses and wandering AV intervals mimicking oversensing or Wenckebach periodicity.ConclusionsRecognizing algorithm-driven ECG patterns requires knowledge of device timing intervals and refractory periods, which lets clinicians distinguish programmed behavior from true malfunction or cardiac arrhythmia.”
- 2ANTITACHYCARDIA PACING: OPTIMAL PROGRAMMING AND PREDICTION OF EFFICACY FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS. STATE OF THE ART AND PERSPECTIVE.Research paper (Avolio et al.)Published Jan 3, 2023Checked Oct 17, 2026
“Introduction: Antitachycardia pacing (ATP) is one of the therapies provided by an implantable cardioverter defibrillator (ICD) for the treatment of ventricular arrhythmias (VA). Successful ATP leads to avoidance of shock, that is related to an increase in mortality and morbidity. Methods and Results : A total of 63 documents have been obtained by using the key term “Antitachycardia pacing” in PubMed, focusing on optimal ATP and ICD programing to reduce inappropriate or avoidable therapies, predictive factors of ATP efficacy and latest technologies and devices still in experimentation. Antitachycardia pacing confirms to be a good therapeutic tool to interrupt ventricular arrhythmias. An optimal ICD programming could lead to the reduction of inappropriate or avoidable ATP therapies. Furthermore, a better knowledge in predictive factors of ATP efficacy not only could better orient physicians on the device to implant, but also could allow for a better arrhythmic risk stratification.”
- 3When the Pacemaker Goes Rogue: Pacemaker-Induced Tachycardia, Syncope, and Car Crash.Case reports in cardiology (Grogg et al.)Published May 26, 2026Checked Oct 17, 2026
“However, atrial threshold testing promptly provoked a PMT. The induced PMT led to a tachycardia of 130 bpm, causing severe symptomatic hypotension with a mean blood pressure falling below 50 mmHg. This could be easily reproduced several times. Given the patient's severe left ventricular systolic dysfunction and the absence of any overt alternative explanation, the PMT likely triggered the syncope preceding the car accident. Management focused on reprogramming the DR ICD. The most critical adaptation was a mode switch from DDD to DDIR to prevent atrial tracking, effectively terminating PMT episodes. A prolongation of the postventricular atrial refractory period (PVARP) was not possible due to the very slow VA conduction. The follow-up revealed no other episodes of PMT and the patient no longer experiences episodes of presyncope or syncope. This report highlights the potential for PMTs to induce severe hemodynamic instability and syncope, underscoring the importance of meticulous device evaluation.”
- 4Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmiasPacing and Clinical Electrophysiology (Crossley et al.)Published Apr 12, 2019Checked Oct 17, 2026
“Of 43,440 qualifying patients, 4,203 had rATP on. Matching resulted in 4,016 pairs, totaling 8,032 patients for analysis. The rATP group experienced significantly lower risks of AT/AF events lasting ≥1 day (HR 0.81), ≥7 days (HR 0.64), and ≥30 days (HR 0.56) compared to control (P < 0.0001 for all). In subgroup analysis, rATP was associated with reduced risks of AT/AF events across age, sex, device type, baseline AT/AF, and preventive atrial pacing. Among real-world patients from a large device database, rATP therapy was significantly associated with a reduced risk of AT/AF. This association was independent of whether the patient had a pacemaker, defibrillator, or resynchronization device.”
- 52021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyEuropean Heart Journal (Glikson et al.)Published Aug 29, 2021Checked Oct 17, 2026
“evant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgement, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.”
How it changed
Published 1 time since Oct 17, 2026.
- Version 2Oct 17, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
“Sensing the heart and pacing when it beats too slowly” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
Open questions
Which patient and arrhythmia characteristics best predict whether antitachycardia pacing will successfully stop a ventricular arrhythmia rather than fail and require a shock?
No answers yet
How often does pacemaker-mediated tachycardia cause severe symptoms such as syncope, and which programming strategies most reliably prevent it?
No answers yet
Does reactive atrial-based ATP itself reduce atrial fibrillation, or is its association with fewer events explained by other differences between patients whose devices had it enabled?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.